Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share ...

Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton Dublilier & Rice, known as CD&R. The two companies shared that they have ...

Bpifrance is expected to participate as a minority shareholder with a c.2% stake in Opella, with Sanofi remaining a significant shareholder. The terms of the transaction remain unchanged from ...

Sanofi (NASDAQ:SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, its consumer healthcare business, to private equity firm CD&R. The terms of ...

Paris, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT ...